 chemotherapi high dose ifosfamide/mesna cisplatin treatment ovarian cancer studi grupo estudio tratamiento latino-americano del cancer twenty-on evalu patient figo ii-iv epitheli ovarian cancer median age rang year ifosfamid IF ml salin solut hour intraven i.v infus day IF dose i.v inject hour IF dose oral rout hour day ml salin solut hour i.v infus day cycl week patient metastat lesion mesenteri pleura colon cervix abdomin wall lung liver bladder node toxic mild patient alopecia nausea neutropenia mild patient mild brain confus patient microscop hematuria complet respons partial respons overal object respons second look perform patient complet respons patient patholog complet respons patholog partial respons median durat complet respons month median partial respons durat month number small data combin chemotherapi high dose ifosfamide/mesna cisplatin activ treatment advanc ovarian carcinoma